반응식
[CH2:1]([C:13]1[NH:17][N:16]=[N:15][N:14]=1)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][CH3:12].C(C1NN=NN=1)CCCCCCCCC.Br[CH2:34][C:35]([O:37][CH2:38][CH3:39])=[O:36].BrC1C=CC=CC=1CC(OCC)=O>>[CH2:1]([C:13]1[N:14]=[N:15][N:16]([CH2:34][C:35]([O:37][CH2:38][CH3:39])=[O:36])[N:17]=1)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][CH3:12]참가 물질
5
실험 절차
When in the general procedure of Example 71 an appropriate amount of 5-dodecyl-1H-tetrazole was substituted for 5-decyl-1H-tetrazole and an appropriate amount of ethyl bromoacetate was substituted for ethyl 2-bromophenylacetate, the title compound was obtained, mp 38°-40° C.
출처 및 근거
- ORD 기록
- ord-ffc20fdd5b544423afabaf4e2ad082bb
- 출처 데이터셋
- uspto-grants-1997_07
- 특허 번호
- US05646170
연결된 노트
불러오는 중…